We investigated the association between alpha‐synuclein (α‐syn) pathology and brain glucose metabolism across the cognitive spectrum of Alzheimer's disease (AD) co‐pathologies. The gene discussed is SNCA; the disease is early-onset autosomal dominant Alzheimer disease.